Biosimilars: Reference Drug Aliquots for Faster Selection and Development of CHO-based Production Processes

Success StoriesBy adminFebruary 8, 2021

“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”

Reference Drug Aliquots: The right control for Assays

Success StoriesBy adminDecember 20, 2020

“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”

Aliquots: A New Solution to the Batch Variability Problem

Success StoriesBy Ingo SchepersAugust 4, 2020

“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”